Drug Approval | August 26, 2021
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
The company to receive upfront and milestone payments, in addition to royalties
The company to receive upfront and milestone payments, in addition to royalties
It strengthens its presence to over 250 stores
This work has been published in the journal ‘ACS applied materials and interface’
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website
Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.
This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific Instrumentation market
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
Subscribe To Our Newsletter & Stay Updated
